Logo

Arbeitsgemeinschaft Deutscher Tumorzentren e.V.

Netzwerk für Versorgung, Qualität und Forschung in der Onkologie

Bild

Veröffentlichungen

Hier finden Sie eine Übersicht einiger Artikel.

Sophia Scharl, Tim Sprötge, Michael Gerken, Anton Scharl, Atanas Ignatov, Elisabeth C Inwald, Olaf Ortmann, Oliver Kölbl, Monika Klinkhammer-Schalke, Thomas Papathemelis
Factors influencing treatment decision and guideline conformity in high-grade endometrial cancer patients: a population-based study
Arch Gynecol Obstet. 2021 Jul 5. doi: 10.1007/s00404-021-06140-5. PMID: 34223974


Lindberg-Scharf P, Steinger B, Koller M, Hofstädter A, Ortmann O, Kurz J, Sasse J, Klinkhammer-Schalke M.
Long-term improvement of quality of life in patients with breast cancer: supporting patient-physician communication by an electronic tool for inpatient and outpatient care.
Support Care Cancer. 2021 Jun 27. doi: 10.1007/s00520-021-06270-1. Online ahead of print. PMID: 34176020


Sandra Windschüttl, Tobias Pukrop, Anne Herrmann, Patricia Lindberg-Scharf, Daniel Heudobler, Wolfgang Herr, Reinhard Andreesen, Monika Klinkhammer-Schalke, Michael Koller
Development of a screening workflow to identify patient needs in an interdisciplinary oncological day clinic [article in German]
Z Evid Fortbild Qual Gesundhwes. 2021 Jun;163:30-37. doi: 10.1016/j.zefq.2021.04.004. Epub 2021 May 21.


Scharl S, Gerken M, Sprötge T, Kronberger K, Scharl A, Ignatov A, Ortmann O, Kölbl O, Klinkhammer-Schalke M, Papathemelis T.
Comparison of survival outcomes and effects of therapy between subtypes of high-grade endometrial cancer - a population-based study.
Acta Oncol. 2021 Apr 27:1-7. doi: 10.1080/0284186X.2021.1914347. PMID: 33905297


Till Markowiak, Beshir Dakkak, Elena Loch, Christian Großer, Monika Klinkhammer-Schalke, Hans-Stefan Hofmann, Michael Ried
Video-assisted pulmonary metastectomy is equivalent to thoracotomy regarding resection status and survival
J Cardiothorac Surg . 2021 Apr 15;16(1):84. doi: 10.1186/s13019-021-01460-8. PMID: 33858453


Till Markowiak, Reiner Neu, Mohammed Khalid Afeen Ansari, Christian Großer, Monika Klinkhammer-Schalke, Hans-Stefan Hofmann, Michael Ried
Surgical cytoreduction and HITOC for thymic malignancies with pleural dissemination
Thorac Cardiovasc Surg. 2021 Mar;69(2):157-164. doi: 10.1055/s-0039-1700883. Epub 2019 Nov 15. PMID: 31731316


Hetterich M, Gerken M, Ortmann O, Inwald EC, Klinkhammer-Schalke M, Eggemann H, Ignatov A.
Adjuvant chemotherapy for breast cancer patients with axillary lymph node micrometastases.
Breast Cancer Res Treat. 2021 Mar 15. doi: 10.1007/s10549-021-06162-2. PMID: 33721148


Finke I, Behrens G, Maier W, Schwettmann L, Pritzkuleit R, Holleczek B, Kajüter H, Gerken M, Mattutat J, Emrich K, Jansen L, Brenner H.
Small‐area analysis on socioeconomic inequalities in cancer survival for 25 cancer sites in Germany.
International Journal of Cancer 2021 Mar 09. doi: 10.1002/ijc.33553


Völkel V, Schatz S, Draeger T, Gerken M, Klinkhammer-Schalke M, Fürst A.
Transanal total mesorectal excision: short- and long-term results of the first hundred cases of a certified colorectal cancer center in Germany.
Surg Endosc. 2021 Mar 1. doi: 10.1007/s00464-021-08384-3. Online ahead of print. PMID: 33650009


Scharl S, Becher C, Gerken M, Scharl A, Anapolski M, Ignatov A, Inwald EC, Ortmann O, Kölbl O, Klinkhammer-Schalke M, Papathemelis T.
Is there a benefit for adjuvant radio(chemo)therapy in early cervical cancer? Results from a population-based study.
Arch Gynecol Obstet. 2021 Feb 11. doi: 10.1007/s00404-021-05989-w. PMID: 33575846


Gennari P, Gerken M, Mészáros J, Klinkhammer-Schalke M, Ortmann O, Eggemann H, Ignatov A.
Minimal-invasive or open approach for surgery of early cervical cancer: the treatment center matters.
Arch Gynecol Obstet. 2021 Jan 22. doi: 10.1007/s00404-020-05947-y. PMID: 33483846


Spanier G, Ugele I, Nieberle F, Symeou L, Schmidhofer S, Brand A, Meier J, Spoerl S, Krupar R, Rümmele P, Siska P, Renner K, Peter K, Gerken M, Beckhove P, Reichert TE, Kreutz M, Singer K.
The predictive power of CD3+ T cell infiltration of oral squamous cell tumors is limited to non-diabetic patients.
Cancer Lett. 2020 Dec 1:S0304-3835(20)30628-5. doi: 10.1016/j.canlet.2020.11.029. PMID: 33276040


P. Hellmund, J. Schmitt, M. Roessler, F. Meier, O. Schoffer
Targeted and Checkpoint Inhibitor Therapy of Metastatic Malignant Melanoma in Germany, 2000–2016


Tobias Robold, Jakob Neumeier, Michael Ried, Reiner Neu, Zsolt Sziklavari, Christian Grosser, Monika Klinkhammer-Schalke, Hans-Stefan Hofmann
Surgical treatment of lung cancer: how has the introduction of the 8th edition of the TNM classification affected guideline-based therapy? [article in German]
Zentralbl Chir. 2020 Dec;145(6):589-596. doi: 10.1055/a-1164-7058. Epub 2020 Jul 6. PMID: 32629508 doi: 10.1055/a-1164-7058


Staubach P, Scharl A, Ignatov A, Ortmann O, Inwald EC, Hildebrandt T, Gerken M, Klinkhammer-Schalke M, Scharl S, Papathemelis T.
Sentinel lymph node detection by means of indocyanine green using the Karl Storz VITOM® fluorescence camera: a comparison between primary sentinel lymph node biopsy versus sentinel lymph node biopsy after neoadjuvant chemotherapy.
J Cancer Res Clin Oncol. 2020 Nov 23. doi: 10.1007/s00432-020-03461-x. Online ahead of print. PMID: 33230583


Spoerl S, Gerken M, Fischer R, Mamilos A, Spoerl S, Wolf S, Pohl F, Klingelhöffer C, Ettl T, Reichert TE, Spanier G.
Lymphatic and vascular invasion in oral squamous cell carcinoma: Implications for recurrence and survival in a population-based cohort study.
Oral Oncol. 2020 Oct 5;111:105009. doi: 10.1016/j.oraloncology.2020.105009. Online ahead of print. PMID: 3303218


Reinert C, Gerken M, Rathberger K, Krueger K, Klinkhammer-Schalke M, Lindberg-Scharf P, Koelbl O, Proescholdt MA, Riemenschneider MJ, Pukrop T, Bumes E, Hutterer M, Hau P.
Single-institution cross-sectional study to evaluate need for information and need for referral to psychooncology care in association with depression in brain tumor patients and their family caregivers.
BMC Psychol. 2020 Sep 10;8(1):96. doi: 10.1186/s40359-020-00460-y. PMID: 32912313


Völkel, V., Draeger, T., Gerken, M., Klinkhammer-Schalke, M., Benz, S., Fürst, A.
Laparoscopic surgery for colon cancer - A systematic review with special focus on real-world data.
coloproctology (2020) 10. September 2020. doi: 10.1007/s00053-020-00481-6


Hellmund P, Schmitt J, Roessler M, Meier F, Schoffer O.
Targeted and Checkpoint Inhibitor Therapy of Metastatic Malignant Melanoma in Germany, 2000-2016.
Cancers (Basel). 2020 Aug 20;12(9):E2354. doi: 10.3390/cancers12092354. PMID: 32825357
Acknowledgement: Cancer Register of Southwest Saxony, Zwickau, Zwickau, Germany; Clinical Cancer Registry Dresden, Dresden, Germany; Clinical Cancer Registry of the Charité Comprehensive Cancer Center, Berlin, Germany; Klinisches Krebsregister Halle, Halle, Germany; Onkologische Qualitätssicherung (QS) in Westfalen-Lippe, Münster, Germany; Tumour Centre Chemnitz, Chemnitz, Germany; Tumour Centre Erfurt, Erfurt, Germany; Tumour Centre Leipzig, Leipzig, Germany; Tumour Centre Oberfranken, Bayreuth, Germany; Tumour Centre Regensburg, Regensburg, Germany; Tumour Centre Ulm/Comprehensive Cancer Centre Ulm (CCCU), Ulm, Germany; Tumour Centre Wiesbaden, Wiesbaden, Germany.


Teufel A, Gerken M, Fürst A, Ebert M, Hohenthanner I, Klinkhammer-Schalke M.
Benefit of adjuvant chemotherapy in high-risk colon cancer: A 17-year population-based analysis of 6131 patients with Union for International Cancer Control stage II T4N0M0 colon cancer.
Eur J Cancer. 2020 Aug 7;137:148-160. doi: 10.1016/j.ejca.2020.06.036. Online ahead of print. PMID: 32777714


Spoerl S, Gerken M, Mamilos A, Fischer R, Wolf S, Nieberle F, Klingelhöffer C, Meier JK, Spoerl S, Ettl T, Reichert TE, Spanier G.
Lymph node ratio as a predictor for outcome in oral squamous cell carcinoma: a multicenter population-based cohort study.
Clin Oral Investig. 2020 Aug 4. doi: 10.1007/s00784-020-03471-6. Online ahead of print. PMID: 32754787


Jansen L, Behrens G, Finke I, Maier W, Gerken M, Pritzkuleit R, Holleczek B, Brenner H; German Cancer Survival Working Group.
Area-Based Socioeconomic Inequalities in Colorectal Cancer Survival in Germany: Investigation Based on Population-Based Clinical Cancer Registration.
Front Oncol. 2020 May 29;10:857. doi: 10.3389/fonc.2020.00857. eCollection 2020. PMID: 32670870


Spanier G, Böttcher J, Gerken M, Fischer R, Roth G, Lehn P, Klingelhöffer C, Meier JK, Fraccaroli A, Tischer J, Ettl T, Klinkhammer-Schalke M, Reichert TE, Spoerl S.
Prognostic value of perioperative red blood cell transfusion and anemia on survival and recurrence in oral squamous cell carcinoma.
Oral Oncol. 2020 May 7;107:104773. doi: 10.1016/j.oraloncology.2020.104773. PMID:32388408


Prantl L, Gerken M, Zeman F, Leitzmann M, Koller M, Klinkhammer-Schalke M, Evert M, Kuehlmann B, Biermann N
Incidence of Anaplastic Large Cell Lymphoma and Breast-Implant-Associated Lymphoma—An Analysis of a Certified Tumor Registry over 17 Years
J. Clin. Med. April, 2020, 9, 1247; doi: 10.3390/jcm9051247


Klinkhammer-Schalke M, Steinger B, Koller M, Zeman F, Fürst A, Gumpp J, Obermaier R, Piso P, Lindberg-Scharf P; Regensburg QoL Study Group.
Diagnosing deficits in quality of life and providing tailored therapeutic options: Results of a randomised trial in 220 patients with colorectal cancer.
Eur J Cancer. 2020 Mar 13;130:102-113. doi: 10.1016/j.ejca.2020.01.025. [Epub ahead of print] PMID:32179445


Papathemelis T, Scharl A, Anapolski M, C Inwald E, Ignatov A, Ortmann O, Gerken M, Klinkhammer-Schalke M, Scharl S.
Value of indocyanine green pelvic lymph node mapping in the surgical approach of cervical cancer.
Arch Gynecol Obstet. 2020 Feb 11. doi: 10.1007/s00404-020-05457-x. [Epub ahead of print] PMID: 32048031


Finke I, Behrens G, Schwettmann L, Gerken M, Pritzkuleit R, Holleczek B, Brenner H, Jansen L; German Cancer Survival Working Group.
Socioeconomic differences and lung cancer survival in Germany: Investigation based on population-based clinical cancer registration.
Lung Cancer. 2020 Feb 4;142:1-8. doi: 10.1016/j.lungcan.2020.01.021. [Epub ahead of print] PMID: 32044589


Schmuck R, Gerken M, Teegen EM, Krebs I, Klinkhammer-Schalke M, Aigner F, Pratschke J, Rau B, Benz S.
Gender comparison of clinical, histopathological, therapeutic and outcome factors in 185,967 colon cancer patients.
Langenbecks Arch Surg. 2020 Jan 31. doi: 10.1007/s00423-019-01850-6. [Epub ahead of print] PMID:32002628


Papathemelis T, Oppermann H, Grafl S, Gerken M, Pauer A, Scharl S, Scharl A, Inwald E, Ignatov A, Ortmann O, Klinkhammer-Schalke M, Hein A, Beckmann MW, Lux MP (2020).
Long-term outcome of patients with intermediate- and high-risk endometrial cancer after pelvic and paraaortic lymph node dissection: a comparison of laparoscopic vs. open procedure.
J Cancer Res Clin Oncol. 2020 Jan 4. doi: 10.1007/s00432-019-03122-8. [Epub ahead of print] PMID: 31901975

 


Völkel V, Draeger T, Schnitzbauer V, Gerken M, Benz S, Klinkhammer-Schalke M, Fürst A. (2019) Surgical treatment of rectal cancer patients aged 80 years and older-a German nationwide analysis comparing short- and long-term survival after laparoscopic and open tumor resection. Eur J Surg Oncol. 2019 May 9. pii: S0748-7983(19)30443-3. doi:10.1016/j.ejso.2019.05.005. [Epub ahead of print] PMID: 31092363


Voelkel V, Draeger T, Groothuis-Oudshoorn CGM, de Munck L, Hueting T, Gerken M, Klinkhammer-Schalke M, Lavric M, Siesling S. (2019) Predicting the risk of locoregional recurrence after early breast cancer: an external validation of the Dutch INFLUENCE-nomogram with clinical cancer registry data from Germany. J Cancer Res Clin Oncol. 2019 Mar 29. doi: 10.1007/s00432-019-02904-4. [Epub ahead of print] PMID: 30927074


Papathemelis T, Knobloch S, Gerken M, Scharl A, Anapolski M, Ignatov A, Inwald EC, Ortmann O, Scharl S, Klinkhammer-Schalke M. (2019) Impact of nodal status and treatment strategy on overall survival in advanced stage cervical cancer. J Cancer Res Clin Oncol. 2019 Mar 18. doi: 10.1007/s00432-019-02890-7


Draeger T, Völkel V, Schnitzbauer V, Gerken M, Benz S, Klinkhammer-Schalke M, Fürst A. (2019) Laparoscopic and open resection of rectal cancer-is age an effect modifier for short- and long-term survival? Int J Colorectal Dis. 2019 Feb 18. doi: 10.1007/s00384-019-03265-7. [Epub ahead of print] PMID: 30778670


Wimmer T, Ortmann O, Gerken M, Klinkhammer-Schalke M, Koelbl O, Inwald EC. (2019) Adherence to guidelines and benefit of adjuvant radiotherapy in patients with invasive breast cancer: results from a large population-based cohort study of a cancer registry. Arch Gynecol Obstet. 2019 Jan 4. doi.org/10.1007/s00404-018-5030-z [Epub ahead of print] PMID: 30607594

 


Seliger C, Schaertl J, Gerken M, Luber C, Proescholdt M, Riemenschneider MJ, Leitzmann MF, Hau P, Klinkhammer-Schalke M. (2018) Use of statins or NSAIDs and survival of patients with high-grade glioma.

Int J Colorectal Dis. 2018 Aug 21. PLoS ONE 2018 Dec 13(12): e0207858. doi.org/10.1371/journal


Piso P, Stierstorfer K, Gerken M, Klinkhammer-Schalke M.(2018) Benefit of cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy in patients with isolated peritoneal metastases from colorectal cancer.
Int J Colorectal Dis. 2018 Aug 21. doi.org/10.1007/s00384-018-3146-z [Epub ahead of print] PMID:30132068


Seliger C, Luber C, Gerken M, Schaertl J, Proescholdt M, Riemenschneider MJ, Meier CR, Bogdahn U, Leitzmann MF, Klinkhammer-Schalke M, Hau P. (2018) Use of metformin and survival of patients with high-grade glioma. Int J Cancer. 2018 Aug 9. doi: 10.1002/ijc.31783 [Epub ahead of print] PMID:30091464


Papathemelis T, Hassas D, Gerken M, Klinkhammer-Schalke M, Scharl A, Lux MP, Beckmann MW, Scharl S. (2018) Is there a benefit of lymphadenectomy for overall and recurrence-free survival in type I FIGO IB G1-2 endometrial carcinoma? A retrospective population-based cohort analysis. J Cancer Res Clin Oncol. 2018 Jul 23. doi: 10.1007/s00432-018-2715-4 [Epub ahead of print] PMID: 30039227


Ott C, Gerken M, Hirsch D, Fest P, Fichtner-Feigl S, Munker S, Schnoy E, Stroszczynski C, Vogelhuber M, Herr W, Evert M, Reng M, Schlitt HJ, Klinkhammer-Schalke M, Teufel A. (2018) Advanced Mucinous Colorectal Cancer: Epidemiology, Prognosis and Efficacy of Chemotherapeutic Treatment. Digestion. 2018 Jun 5;98(3):143-152. doi: 10.1159/000487710 PMID: 29870979


Munker S, Gerken M, Fest P, Ott C, Schnoy E, Fichtner-Feigl S, Wiggermann P, Vogelhuber M, Herr W, Stroszczynski C, Schlitt HJ, Evert M, Reng M, Klinkhammer-Schalke M, Teufel A. (2018) Chemotherapy for metastatic colon cancer: No effect on survival when the dose is reduced due to side effects. BMC Cancer. 2018 Apr 23;18(1):455. doi: 10.1186/s12885-018-4380-zPMID: 29685155


Völkel V, Draeger T, Gerken M, Fürst A, Klinkhammer-Schalke M.(2018) Langzeitüberleben von Patienten mit Kolon- und Rektumkarzinomen: Ein Vergleich von Darmkrebszentren und nicht zertifizierten Krankenhäusern - [Long-Term Survival of Patients with Colon and Rectum Carcinomas: Is There a Difference Between Cancer Centers and Non-Certified Hospitals?]. Gesundheitswesen. 2018 Apr 19. doi: 10.1055/a-0591-3827 PMID: 29672814


Draeger T, Völkel V, Gerken M, Klinkhammer-Schalke M, Fürst A (2018). Long-term oncologic outcomes after laparoscopic versus open rectal cancer resection: a high-quality population-based analysis in a Southern German district. Surg Endosc. 2018 Apr 2. doi: 10.1007/s00464-018-6148-6. PMID: 29611044


Völkel V, Draeger T, Gerken M, Klinkhammer-Schalke M, Fürst A (2018). Long-term oncologic outcomes after laparoscopic vs. open colon cancer resection: a high-quality population-based analysis in a Southern German district. Surg Endosc. 2018 Mar 30. doi: 10.1007/s00464-018-6158-4. PMID: 29602999


Reinert C, Rathberger K, Klinkhammer-Schalke M, Kölbl O, Proescholdt M, Riemenschneider MJ, Schuierer G, Hutterer M, Gerken M, Hau P (2018). Information needs and requirements in patients with brain tumours and their relatives. J Neurooncol 2018 Mar 7. doi.org/10.1007/s11060-018-2811-y PMID: 29516343


Liebig-Hörl G, Puchner C, Gerken M, Klinkhammer-Schalke M, Fürst A (2018). Therapeutische Strategie bei Frühkarzinom im Rektum (T1-Karzinom) [Treatment strategy for early stage rectal cancer (T1 carcinoma)]. Chirurg 2018 Feb 14 doi: 10.1007/s00104-018-0603-8  PMID: 29445855


Papathemelis Th, Jablonsky E, Hauzenberger T, Scharl A, Gerken M, Klinkhammer-Schalke M, Hipp M, Scharl S (2018). Sentinel lymph node biopsy (SLNB) in breast cancer patients by means of indocyanine green (ICG) using the Karl Storz VITOM fluorescence camera. BioMed Research International Volume 2018 (2018), doi.org/10.1155/2018/6251468


Scharl S, Papathemelis T, Kronberger K, Gerken M, Scharl A, Kölbl O, Klinkhammer-Schalke M (2018). Does post-operative radiochemotherapy improve survival in high-grade endometrial cancer patients? Results of a population-based cohort analysis of a cancer registry. Arch Gynecol Obstet. 2018 Feb 7. doi: 10.1007/s00404-018-4708-6. [Epub ahead of print]

 


Haj A, Doenitz Ch, Schebesch KM, Ehrensberger D, Hau P, Putnik K, Riemenschneider MJ, Wendl Ch, Gerken M, Pukrop T, Brawanski A, Proescholdt MA (2017). Extent of Resection in Newly Diagnosed Glioblastoma: Impact of a Specialized Neuro-Oncology Care Center. Brain Sci. 2018, 8, 5; http://dx.doi.org/10.3390/brainsci8010005, PMID: 29295569

 

Papathemelis T, Scharl S, Kronberger K, Gerken M, Scharl A, Pauer A, Klinkhammer-Schalke M (2017). Survival benefit of pelvic and paraaortic lymphadenectomy in high‑grade endometrial carcinoma: a retrospective population‑based cohort analysis. J Cancer Res Clin Oncol, pp 1–8http://dx.doi.org/10.1007/s00432-017-2508-1, PMID: 28840384

 

Klinkhammer-Schalke M, Steinger B, Koller M, Lindberg P (2017). Lebensqualitätsinterventionen in der Onkologie. Z. Evid. Fortbild. Qual. Gesundh. wesen (ZEFQ). http://dx.doi.org/10.1016/j.zefq.2017.04.005

 

Lindberg P, Netter P, Koller M, Steinger B, Klinkhammer-Schalke M (2017). Breast cancer survivors` recollection of their quality of life: identifying determinants of recall bias in a longitudinal population-based trial. PLoS ONE. http://dx.doi.org/10.1371/journal.pone.0171519

 

Inwald EC, Ortmann O, Koller M, Zeman F, Hofstädter F, Evert M, Brockhoff G, Klinkhammer-Schalke M (2017). Screening-relevant age threshold of 70 years and older is a stronger determinant for the choice of adjuvant treatment in breast cancer patients than tumor biology. Breast Cancer Res Treat, 163:119-130. http://dx.doi.org/10.1007/s10549-017-4151-6

 

Klinkhammer-Schalke M, Gerken M, Barlag H, Hofstädter F, Benz S (2017). Bedeutung von Krebsregistern für die Versorgungsforschung - Registerstudien vs. klinische Studien am Beispiel des Kolonkarzinoms. Onkologe, 23:280-287. http://dx.doi.org/10.1007/s00761-016-0181-7

 

Was können Klinische Krebsregister in Zukunft für die bevölkerungsbezogene Umsetzung evidenzbasierter Leitlinien leisten?

Artikel in ELSEVIER Urban & Fischer, ZefQ
von M. Klinkhammer-Schalke, M. Gerken, H. Barlag, A. Tillack

 


Breast cancer survivors´recollection of their illness and therapy seven years after enrolment into a randomised controlled clinical trail

Beitrag in BMC Cancer (2015) 15:554, DOI 10.1186/s12885-015-1573-6
von P. Lindberg, M. Koller, B. Steinger, W.Lorenz, J.C. Wyatt, E.C. Inwald, M. Klinkhammer-Schalke


Der Nationale Krebsplan - Ziele, Umsetzung und Konsequenzen

Beitrag in der Zeitschrift für den Chirurgen "Chirurgische Praxis", Juni 2014 78/Heft 1
von O. Ortmann, S. Buchholz, M. Klinkhammer-Schalke


Lebensqualität bei Brustkrebs-Patientinnen-Implementierung und Umsetzung in die Routineversorgung

Artikel in der Zeitschrift des Deutschen Gesellschaft für Gynäkologie und Geburtshilfe e.V. (DGGG), 
Geburtsh. Frauenheilk 2014;74
von M. Klinkhammer-Schalke, P. Lindberg, M. Koller, B. Steinger, O. Ortmann, A. Hofstädter, A. Scharl, E. C. Inwald, W. Lorenz


Fit für die Umsetzung des Krebsfrüherkennungs- und -registergesetzes?

Artikel im Mitteilungsblatt der Sächsischen Krebsgesellschaft e.V., Ausgabe 2/2014von R. Lange, C. Matthes, G. Schmieder, B. Schubotz, J.Wohlgemuth, J. Wulff, V. Wulff


Ki-67 is a prognostic parameter in breast cancer patients: results of a large population-based cohort of a cancer registry

Artikel in Springerllink.com, Breast Cancer Res Treat (2013) 139:539–552, DOI 10.1007/s10549-013-2560-8
von E.C. Inwald, M. Klinkhammer-Schalke, F. Hofstädter, F. Zeman, M. Koller, M. Gerstenhauer, O. Ortmann


Der Nationale Krebsplan aus Sicht der klinischen und epidemiologischen Register

Artikel in mdi, Forum der Medizin_Dokumentation und Medizin_Informatik, Heft 2, Juni 2013, Jahrgang 15
von Frau Priv. Doz. Dr. M. Klinkhammer-Schalke und Herrn Prof. Dr. A. Katalinic


Umsetzung der S3-Leitlinie zur Prävention, Diagnostik, Therapie und Nachsorge des Lungenkarzinoms im Land Berlin

Artikel in der Zeitschrift Pneumologie 2013; 67(02) :118-122
von Herr Dr. T. Blum, Dr. N. Schönfeld, Prof. Dr. G. Goeckenjan und Frau Dr. A. Jagota


Versorgungssituation beim Lungenkarzinom in Deutschland - Ergebnisse einer Auswertung bundesweiter Daten klinischer Krebsregister

Abstract beim 54. Kongress der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin e.V. 2013 in Hannover
von Herr Dr. T. Blum


Integration und Steuerfunktion klinischer Krebsregister in der onkologischen Versorgung

Artikel im Forum 06.2012, Volume 27, Issue 6, pp 431-435 
von Dr. TG Blum MBA, Dr. N. Schönfeld, Dr. A. Jagota, Dr. M. Klinkhammer-Schalker


Register in der onkologischen Versorgungsforschung

Artikel in Der Onkologe 2012 Band 18 Heft 2 Seite 142-150 
von Frau Dr. M. Klinkhammer-Schalke, Dr. N. Marschner und Herrn Prof. Dr. F. Hofstädter


Optimale Zusammenarbeit von Klinikern und Pathologen in der Tumordiagnostik

Artikel im Forum 01.2012 von Prof. Dr. C. Wittekind und Prof. Dr. F. Hofstädter


Aufgaben und Strukturen für die klinische Krebsregsistrierung

Artikel in Der Onkologe 2011 Band 17 Heft 2 Seite 121-125 
von Herrn Prof. Dr. F. Hofstädter und Frau Dr. M. Klinkhammer-Schalke


Versorgungsforschung mit Krebsregistern

Artikel in Der Onkologe 2011 Band 17 Heft 12 Seite 143-152 von Herrn Prof. Dr. D. Hölzel


Status quo der Zusammenarbeit von Klinischen Krebsregistern und Organkrebszentren 

Artikel im Forum 04.2010 von Frau Dr. M. Klinkhammer-Schalke und Frau Dr. S. Wesselmann (DKG)


Klinische Krebsregister

Neue Entwicklungen nach der nationlen Krebskonferenz

Artikel im Forum 02.2010 von Herrn Prof. Dr. F. Hofstädter und Frau Dr. M. Klinkhammer-Schalke


Kombination von medizinischen und hermeneutischen Ergebnissen in der Versorgungsforschung

Bessere Chancen für beides: Überleben und Lebensqualität

Artikel im Forum 05.2009 von Frau Dr. M. Klinkhammer-Schalke


 "Was leisten Tumorregister für die Qualitätssicherung in der Onkologie?"

Artikel in Der Onkologe 2008 von Herrn Prof. Dr. F. Hofstädter und Herrn Prof. Dr. H. Hölzel